VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $54,000 | -92.0% | 2,023 | -69.4% | 0.00% | -100.0% |
| Q4 2015 | $673,000 | -99.2% | 6,618 | -98.6% | 0.00% | -99.1% |
| Q3 2015 | $84,941,000 | -30.6% | 476,181 | -13.6% | 0.12% | -24.3% |
| Q2 2015 | $122,468,000 | +5.9% | 551,286 | -5.3% | 0.15% | +0.7% |
| Q1 2015 | $115,600,000 | -32.3% | 582,014 | -51.2% | 0.15% | -33.2% |
| Q4 2014 | $170,674,000 | -2.7% | 1,192,607 | -10.8% | 0.23% | -7.8% |
| Q3 2014 | $175,340,000 | +34.4% | 1,336,433 | +29.2% | 0.24% | +40.0% |
| Q2 2014 | $130,480,000 | +7.2% | 1,034,572 | +12.1% | 0.18% | -1.1% |
| Q1 2014 | $121,672,000 | +11.3% | 922,943 | -0.9% | 0.18% | +9.3% |
| Q4 2013 | $109,299,000 | +117.1% | 930,998 | +92.9% | 0.16% | +95.2% |
| Q3 2013 | $50,342,000 | +106.1% | 482,528 | +70.0% | 0.08% | +88.6% |
| Q2 2013 | $24,426,000 | – | 283,765 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |